This paper describes the composition of a formula (I) compound used to treat cancer.Certain models are related to cancer treatment methods, which collectively manage one formulation (I) compound and one or more immune checkpoint inhibitors for use by the target audience.So am I Some models involve cancer treatment, which combines a formula (I) compound with Principi to target patients requiring the same treatment.Some models involve methods of providing joint stimuli to the co-management of a formula (I) compound for T-cancer cell activity.One or more immunological checkpoint inhibitors
展开▼
